Does a high AA/EPA or omega-6/omega-3 ratio prime inflammatory signaling?

An elevated dietary omega-6 to omega-3 ratio significantly shifts cell membrane composition and downstream lipid mediator profiles, driving a systemic environment primed for thrombo-inflammation.

Enzymatic Competition and Eicosanoid Synthesis

• Substrate Competition: Arachidonic acid (AA, omega-6) and eicosapentaenoic acid (EPA, omega-3) directly compete for incorporation into membrane phospholipids and active sites on cyclooxygenase (COX-1/COX-2) and 5-lipoxygenase (5-LOX) enzymes.
• Eicosanoid Bias: High AA/EPA ratios (typically 15:1 to 20:1 in Western diets) saturate membranes with AA, biasing enzymatic pathways toward pro-inflammatory 2-series prostaglandins (PGE2) and 4-series leukotrienes (LTB4). Lowering the AA/EPA ratio to approximately 0.2 competitively displaces AA, reducing PGE2 synthesis by up to 50% in favor of less potent 3-series prostaglandins and 5-series leukotrienes.

Mechanistic Pathways of Inflammatory Priming

• GPCR and Calcium Signaling: AA-derived LTB4 binds GPCRs (BLT1/BLT2) on leukocytes, triggering Gq- and Gi-mediated signaling that elevates intracellular calcium ($[Ca^{2+}]_i$). This initiates inside-out signaling via the Rap1-Talin1-Kindlin-3 cascade.
• Integrin Activation and Aggregation: This cascade induces conformational changes and clustering of leukocyte β2-integrins (Mac-1 and LFA-1). Activated Mac-1 binds platelet GPIbα or active αIIbβ3, stabilizing leukocyte-platelet aggregates and driving vascular inflammation.
• Vascular Signaling Balance: Concurrent AA conversion to thromboxane A2 ($TXA_2$) drives robust, Gq-dependent platelet activation and aggregation, while PGE2 modulates this response through EP receptor subtypes, dynamically balancing cAMP levels and calcium release.

Bottom line

• Key Takeaway: An elevated AA/EPA ratio shifts enzymatic pathways to favor AA-derived eicosanoids like LTB4 and PGE2. These mediators prime leukocyte and platelet inflammatory signaling, activate β2-integrins, and stabilize thrombo-inflammatory aggregates.